Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00023311
DRKS00023311
Completed
Not Applicable

Association of inflammatory markers in depressed patients with cognitive dysfunction - IMDEC

Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg0 sites70 target enrollmentOctober 20, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsF33F31Recurrent depressive disorderBipolar affective disorder

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F33
Sponsor
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg
Enrollment
70
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2020
End Date
March 1, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg

Eligibility Criteria

Inclusion Criteria

  • •patients aged between 18 and 60 who are able to give consent
  • •inpatient treatment due to a depressive episode (ICD\-10 F31, F32, F33; HAMD\-21: 18\-30\)
  • •after written informed consent

Exclusion Criteria

  • •pregnant or brest\-feeding women
  • •drug or alcohol dependence
  • •depressive episode secondary of a somatic/neurological illness or substance abuse
  • •severe somatic or neurological illness which can impair results (e.g. Morbus Cushing, rheumathoid illness)
  • •other psychiatric comorbidities
  • •The patient cannot understand the scope of the study and is not capable of giving consent.
  • •admission to hospital not voluntary
  • •regular intake of steroids or non\-steroidal antiphlogistics (NSAID)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Inflammatory Markers and Resistant DepressionDepression
NCT02847533Centre Hospitalier Universitaire de Besancon108
Completed
Not Applicable
Major Depression and Inflammatory Risk Markers for Coronary Heart DiseaseDepression
NCT00037505National Center for Research Resources (NCRR)
Completed
Early Phase 1
Inflammation-Induced Depressed Mood: The Role of Social Neurocognitive MechanismsDepression
NCT01671150University of California, Los Angeles100
Completed
Not Applicable
Peripheral Immunomarker Validation in Treatment-resistant DepressionDepressive Disorder, Major
NCT02752178University of Cambridge393
Completed
Not Applicable
The influence of depression and neuroinflammation on the progression of mild cognitive impairment to dementia: PET imaging of amyloid deposition and microglia activatiolate onset depressionMild cognitive impairment1004225810012272
NL-OMON32861niversitair Medisch Centrum Groningen48